Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JieYuSuFei
- Development stage
- Preclinical
- Lead developer
- Xiyuan Hospital
- Administration
- Oral
01
Overview
JieYuSuFei (also referred to as "Jieyu Sufei Decoctio") is a traditional Chinese medicine formulation studied for the treatment of chronic persistent stage bronchial asthma. It is used as part of an integrative approach in Traditional Chinese Medicine (TCM) and is administered as a decoction. The precise herbal composition, mechanism of action, and pharmacological targets are not specified in available clinical trial records. Its use aligns with TCM principles rather than Western pharmacology, and it is not classified under standard pharmaceutical drug categories.
- Brand names
- JieYuSuFei
- Other names
- Jieyu Sufei Decoctio
Beyond the preview
Go deeper on JieYuSuFei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JieYuSuFei.